Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection
暂无分享,去创建一个
D. Pakstis | K. Shutt | J. Pilewski | K. McCurry | K. Raza | S. Husain | M. Crespo | A. Zeevi | D. Zaldonis | K. Spichty | C. Bentlejewski | M. Carey | Y. Toyoda | M. E. Carey
[1] W. Vigneswaran,et al. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] W. S. Ring,et al. Utility of the Cylex assay in cardiac transplant recipients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] Valerie B. Sampson,et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. , 2008, Journal of pediatric surgery.
[4] S. Husain,et al. Fungal infections in lung transplant recipients , 2008, Current opinion in pulmonary medicine.
[5] P. Friend,et al. Homeostatic Repopulation by CD28−CD8+ T Cells in Alemtuzumab‐Depleted Kidney Transplant Recipients Treated With Reduced Immunosuppression , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] Nina Singh,et al. Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients , 2007, Transplantation.
[7] L. Carruth,et al. Recovery of Functional Memory T Cells in Lung Transplant Recipients Following Induction Therapy with Alemtuzumab , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] D. Paterson,et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] J. Fung,et al. Pancreas Transplantation Under Alemtuzumab (Campath-1H) and Tacrolimus: Correlation Between Low T-Cell Responses and Infection , 2006, Transplantation.
[10] D. Paterson,et al. Variation in antifungal prophylaxis strategies in lung transplantation , 2006, Transplant infectious disease : an official journal of the Transplantation Society.
[11] D. Pakstis,et al. Voriconazole Prophylaxis in Lung Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] T. Giese,et al. Pharmacodynamic Monitoring of Cyclosporine A in Renal Allograft Recipients Shows a Quantitative Relationship Between Immunosuppression and the Occurrence of Recurrent Infections and Malignancies , 2006, Transplantation.
[13] A. Humar,et al. American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] D. Guaspari,et al. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. , 2005, Transplant immunology.
[15] T. Starzl,et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. , 2005, The Journal of thoracic and cardiovascular surgery.
[16] Nina Singh,et al. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] F. Pereyra,et al. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients , 2004, Current opinion in infectious diseases.
[18] A. Heredia,et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management , 2003, Clinical transplantation.
[19] N. Smedira,et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[20] R. Speich,et al. Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] D. Snydman. Infection in solid organ transplantation , 1999, Transplant infectious disease : an official journal of the Transplantation Society.
[22] A. Pukhalsky,et al. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. , 1999, Mediators of inflammation.
[23] G. Berry,et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[24] E. Alexopoulos,et al. Urinary tract infections after renal transplantation. , 1985, Drugs under experimental and clinical research.